analyst
AD
NYSE · ADCT
ADC Therapeutics S.A.
Healthcare · Biotechnology
$1.10
Down-$0.03 (-2.73%)
Updated Aug 18, 2026, 2:29 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 507.9M
- P/E ratio
- -3.35
- Dividend yield
- 0.00%
- 52-week range
- $0.78 – $4.98
- Volume
- 3.73M
- Avg. volume
- 1.16M
Price performance
ADCT price history
1M range · 21 trading sessions · Daily adjusted prices
ADCT closed at $1.10 after 21 trading sessions, down 12.70% for the selected period.
- Last close
- $1.10
- Period change
- -12.70%
- Period low
- $1.01
- Period high
- $1.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 17, 2026 | $0.99 | $1.10 | $0.95 | $1.10 | 3.73M |
| Aug 14, 2026 | $1.02 | $1.04 | $1.00 | $1.01 | 1.35M |
| Aug 13, 2026 | $1.07 | $1.10 | $0.9393 | $1.05 | 2.19M |
| Aug 12, 2026 | $1.20 | $1.23 | $1.155 | $1.23 | 563.56K |
| Aug 11, 2026 | $1.11 | $1.20 | $1.11 | $1.18 | 664.34K |
| Aug 10, 2026 | $1.14 | $1.17 | $1.12 | $1.13 | 569.55K |
| Aug 7, 2026 | $1.08 | $1.17 | $1.08 | $1.13 | 534.56K |
| Aug 6, 2026 | $1.07 | $1.13 | $1.07 | $1.13 | 722.74K |
| Aug 5, 2026 | $1.11 | $1.15 | $1.07 | $1.07 | 971.14K |
| Aug 4, 2026 | $1.05 | $1.12 | $1.04 | $1.10 | 1.37M |
| Aug 3, 2026 | $1.07 | $1.08 | $1.03 | $1.05 | 866.39K |
| Jul 31, 2026 | $1.11 | $1.12 | $1.045 | $1.05 | 757.73K |
| Jul 30, 2026 | $1.09 | $1.13 | $1.07 | $1.11 | 887.74K |
| Jul 29, 2026 | $1.10 | $1.125 | $1.0712 | $1.10 | 924.5K |
| Jul 28, 2026 | $1.14 | $1.151 | $1.10 | $1.11 | 747.77K |
| Jul 27, 2026 | $1.18 | $1.21 | $1.12 | $1.14 | 787.75K |
| Jul 24, 2026 | $1.25 | $1.26 | $1.145 | $1.15 | 725.75K |
| Jul 23, 2026 | $1.20 | $1.24 | $1.195 | $1.22 | 579.88K |
| Jul 22, 2026 | $1.24 | $1.285 | $1.21 | $1.24 | 787.17K |
| Jul 21, 2026 | $1.24 | $1.30 | $1.24 | $1.27 | 861.18K |
| Jul 20, 2026 | $1.33 | $1.40 | $1.26 | $1.26 | 659.55K |
Latest ADCT news
The latest Smart Investors Daily articles mentioning ADCT.
Stock researchCompany · Financials
Loading stock research…